Genomed Spolka Akcyjna Logo

Genomed Spolka Akcyjna

Biotechnology firm for genetic research and molecular diagnostics using NGS technology.

GEN | WAR

Overview

Corporate Details

ISIN(s):
PLGNOMD00024 (+3 more)
LEI:
259400MZZJNF1JFWAG26
Country:
Poland
Address:
Warszawa Ponczowa 12, 02-971 Warszawa

Description

Genomed Spolka Akcyjna is a biotechnology company specializing in genetic research and molecular diagnostics. It offers a comprehensive range of services centered on DNA and RNA sequencing, analysis, and synthesis, primarily utilizing Next Generation Sequencing (NGS) technology. The company's core activities include the analysis of gene sequences to identify mutations responsible for congenital diseases, with the capability to analyze thousands of genes. Genomed serves both the clinical diagnostics and research sectors, providing services to the medical and biotechnological markets. A key strategic focus is the development and introduction of genomic technologies into personalized medicine, aiming to advance genomic prevention and gene treatments in medical practice.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-02-16 12:55
Zaproszene - akcje nienotowane na NC
Polish 490.7 KB
2021-02-16 12:55
Zaproszenie - akcje notowane na NC
Polish 496.4 KB
2021-02-16 12:55
Skup akcji własnych Emitenta - publikacja zaproszenia do składania ofert i poda…
Polish 371 bytes
2021-02-15 16:18
Regulamin skupu akcji własnych
Polish 133.2 KB
2021-02-15 16:18
Podjęcie przez Zarząd Emitenta Uchwały w sprawie ustalenia szczegółowych warunk…
Polish 966 bytes
2021-01-13 15:58
Lista akcjonariuszy ponad 5% NWZA Genomed SA
Polish 306.4 KB
2021-01-13 15:58
Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Nadzwyczajnym…
Polish 336 bytes
2020-12-10 16:35
Projekty uchwał
Polish 193.5 KB
2020-12-10 16:35
Ogłoszenie o zwołaniu NWZA
Polish 467.3 KB
2020-12-10 16:35
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Akcjonariuszy GENOMED S.A. - Conte…
Polish 514 bytes
2020-11-24 08:53
Piąte wezwanie akcjonariuszy do złożenia dokumentów akcji - Content (PL)
Polish 567 bytes
2020-11-05 10:11
Czwarte wezwanie akcjonariuszy do złożenia dokumentów akcji - Content (PL)
Polish 567 bytes
2020-10-12 12:19
Trzecie wezwanie akcjonariuszy do złożenia dokumentów akcji - Content (PL)
Polish 647 bytes
2020-09-17 13:06
Drugie wezwanie akcjonariuszy do złożenia dokumentów akcji - Content (PL)
Polish 648 bytes
2020-08-27 12:41
Pierwsze wezwanie akcjonariuszy do złożenia dokumentów akcji - Content (PL)
Polish 567 bytes

Automate Your Workflow. Get a real-time feed of all Genomed Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Genomed Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Genomed Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.